1 Product identity
Ingredient risk
2 ingredients to use with caution

Clinical Antiangiogenesis

BrandNatural Clinician→Other Combinations Capsule 20 ingredients 2 caution DSLD #18601
Net contents: 180 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-02-25
2 Ingredients (20)
IngredientGroupSafety
Bovine CartilageCartilage—
ChitinChitin—
N-Acetyl-GlucosamineN-Acetyl Glucosamine—
Chicken CartilageCartilage—
Sea CucumberSea Cucumber—
Quercetin DihydrateQuercetinConditionally Safe
GarlicGarlic—
Green Tea 95% PolyphenolsGreen Tea—
PapainPapainConditionally Safe
Aloe vera 200:1 extractAloe—
Ellagic AcidEllagic Acid—
Soy Isoflavonesisoflavone (unspecified)—
Magnolia bark extractMagnolia —
Pine Bark ExtractPine (unspecified)—
Vitamin AVitamin AConditionally Safe
Vitamin D3Vitamin DUse with Caution
GelatinGelatin—
CelluloseCellulose—
MagnesiumMagnesiumUse with Caution
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin D — Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Glucosamine — Limited Evidence
⚠ Shellfish allergy
⚠ May affect glucose
Quercetin — Conditionally Safe
⚠ Inhibits CYP3A4
⚠ Affects cyclosporine levels
Papain — Conditionally Safe
⚠ Allergic reactions
⚠ Increased bleeding risk
Grape Seed Extract — Limited Evidence
⚠ Antiplatelet effect
⚠ May interact with anticoagulants
Pine Bark Extract — Limited Evidence
⚠ Mild GI effects
⚠ May lower blood glucose slightly
Vitamin A — Conditionally Safe
⚠ Teratogenic at high doses
⚠ Hepatotoxic with chronic excess
Vitamin D — Use with Caution
⚠ Hypercalcemia at >10,000 IU/day
⚠ Vascular calcification risk
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
5 Data source
DSLD ID18601
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-02-25
6 More from Natural Clinician
View Natural Clinician Safety Scorecard → 28 products
Calorie Restriction MimeticsClinical Advanced Joint CareClinical Advantra ZClinical AllergyClinical Augmented Silver ColloidClinical Chelation Companion
7 Cite this page
Vancouver
Pkhakadze G. Clinical Antiangiogenesis — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/products/clinical-antiangiogenesis-18601/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network